Stocks like Delhivery, SML Isuzu, Hindustan Zinc, Polycab India, RailTel Corporation of India, Zydus Wellness, Vishal Mega ...

It's an old joke that there are three kinds of people in the world: those who are good at math and those who aren't.

Thousands of companies promising to unlock young children’s brain potential have opened in recent years, drawing in eager ...

Salesforce Inc. is in talks to acquire software company Informatica Inc., rebooting a pursuit that fell through last year, people familiar with the matter said. If a deal is reached, it could be ...

AT&T agrees to acquire substantially all of Lumen's Mass Markets fiber internet connectivity business in a deal that's expected to close in the first half of 2026 Transaction to stimulate ...

More than two months after filing for Chapter 11, 23andMe has found a buyer in Regeneron Pharmaceuticals, which has agreed to acquire substantially all the bankrupt direct-to-consumer genetic ...

Robinhood Markets Inc. agreed to acquire WonderFi Technologies Inc., the operator of two Canadian cryptocurrency platforms, for about C$250 million ($179 million) in cash. The fintech will ...

Brokerage fintech Robinhood is set to acquire WonderFi, a Canadian crypto firm, for about 250 million Canadian dollars ($179 million) in an all-cash deal to expand its global presence. The ...

Bitcoin and crypto exchange Coinbase has agreed to acquire derivatives trading platform Deribit for $2.9 billion, marking the largest acquisition in the industry’s history. Coinbase will acquire ...

It’s no wonder that Samsung wants to acquire them. Bowers & Wilkins is reportedly not the only audio brand that Samsung wants to buy, however. At least according to the rumor. Samsung to acquire ...

Big data integration firm Fivetran Inc. today announced that it has signed an agreement to acquire universal data platform company Census for an undisclosed price. Founded in 2018 as Sutro ...

But will Pfizer choose to acquire either Altimmune or Viking? I'm not sure. Although danuglipron is no longer a contender, Pfizer still has another experimental oral obesity drug in phase 2 ...